scispace - formally typeset
Search or ask a question
Journal ArticleDOI

Prevalence and Characteristics of Undiagnosed Bipolar Disorders in Patients With a Major Depressive Episode: The BRIDGE Study

TL;DR: Family history, illness course, and clinical status, in addition to DSM-IV-TR criteria, may provide useful information for physicians when assessing evidence of bipolarity in patients with major depressive episodes, and is recommended before deciding on treatment.
Abstract: Context Major depressive disorder, the most common psychiatric illness, is often chronic and a major cause of disability. Many patients with major depressive episodes who have an underlying but unrecognized bipolar disorder receive pharmacologic treatment with ineffective regimens that do not include mood stabilizers. Objective To determine the frequency of bipolar disorder symptoms in patients seeking treatment for a major depressive episode. Design Multicenter, multinational, transcultural, cross-sectional, diagnostic study. The study arose from the initiative Bipolar Disorders: Improving Diagnosis, Guidance and Education (BRIDGE). Setting Community and hospital psychiatry departments. Patients Participants included 5635 adults with an ongoing major depressive episode. Main Outcome Measures The frequency of bipolar disorder was determined by applying both DSM-IV-TR criteria and previously described bipolarity specifier criteria. Variables associated with bipolarity were assessed using logistic regression. Results A total of 903 patients fulfilled DSM-IV-TR criteria for bipolar disorder (16.0%; 95% confidence interval, 15.1%-17.0%), whereas 2647 (47.0%; 95% confidence interval, 45.7%-48.3%) met the bipolarity specifier criteria. Using both definitions, significant associations (odds ratio > 2; P Conclusions The bipolar-specifier criteria in comparison with DSM-IV-TR criteria were valid and identified an additional 31% of patients with major depressive episodes who scored positive on the bipolarity criteria. Family history, illness course, and clinical status, in addition to DSM-IV-TR criteria, may provide useful information for physicians when assessing evidence of bipolarity in patients with major depressive episodes. Such an assessment is recommended before deciding on treatment.
Citations
More filters
Journal ArticleDOI
TL;DR: The British Association for Psychopharmacology guidelines specify the scope and targets of treatment for bipolar disorder, and recommend strategies for the use of medicines in short-term treatment of episodes, relapse prevention and stopping treatment.
Abstract: The British Association for Psychopharmacology guidelines specify the scope and targets of treatment for bipolar disorder. The third version is based explicitly on the available evidence and presented, like previous Clinical Practice Guidelines, as recommendations to aid clinical decision making for practitioners: it may also serve as a source of information for patients and carers, and assist audit. The recommendations are presented together with a more detailed review of the corresponding evidence. A consensus meeting, involving experts in bipolar disorder and its treatment, reviewed key areas and considered the strength of evidence and clinical implications. The guidelines were drawn up after extensive feedback from these participants. The best evidence from randomized controlled trials and, where available, observational studies employing quasi-experimental designs was used to evaluate treatment options. The strength of recommendations has been described using the GRADE approach. The guidelines cover the diagnosis of bipolar disorder, clinical management, and strategies for the use of medicines in short-term treatment of episodes, relapse prevention and stopping treatment. The use of medication is integrated with a coherent approach to psychoeducation and behaviour change.

989 citations


Cites background from "Prevalence and Characteristics of U..."

  • ...DSM-5 has introduced the concept of a mixed features specifier (see below), which formalizes the identification of manic symptoms in depressive episodes (Angst et al., 2011)....

    [...]

  • ...001) with bipolarity were observed for family history of mania/hypomania, multiple past mood episodes and comorbid substance use disorder (Angst et al., 2011)....

    [...]

Journal ArticleDOI
05 Feb 2014-Neuron
TL;DR: Genome-wide association and linkage results provide constraints on the allele frequencies and effect sizes of susceptibility loci, which are used to interpret the voluminous candidate gene literature.

507 citations

Journal ArticleDOI
TL;DR: A consensus was reached on 12 statements on the use of antidepressants in bipolar disorder, and antidepressants should be prescribed only as an adjunct to mood-stabilizing medications.
Abstract: A task force report presents 12 recommendations for antidepressant use in bipolar disorder rated by at least 80% of International Society for Bipolar Disorders experts as essential or important.

475 citations


Cites background from "Prevalence and Characteristics of U..."

  • ...A large long-term study (71) found that among patients in a major depressive episode, those meeting criteria for bipolar features (72, 73) showed a higher risk of later episodes of hypomania or mania and greater mood lability during antidepressant treatment....

    [...]

Journal ArticleDOI
TL;DR: The identification of objective biomarkers that represent pathophysiologic processes that differ between bipolar disorder and unipolar depression can both inform bipolar disorder diagnosis and provide biological targets for the development of new and personalised treatments.

457 citations

Journal ArticleDOI
TL;DR: The results suggest that MDD and BD are characterised by both common and distinct patterns of grey-matter volume changes, which has the potential to inform the development of diagnostic biomarkers for these conditions.
Abstract: Finding robust brain substrates of mood disorders is an important target for research. The degree to which major depression (MDD) and bipolar disorder (BD) are associated with common and/or distinct patterns of volumetric changes is nevertheless unclear. Furthermore, the extant literature is heterogeneous with respect to the nature of these changes. We report a meta-analysis of voxel-based morphometry (VBM) studies in MDD and BD. We identified studies published up to January 2015 that compared grey matter in MDD (50 data sets including 4101 individuals) and BD (36 data sets including 2407 individuals) using whole-brain VBM. We used statistical maps from the studies included where available and reported peak coordinates otherwise. Group comparisons and conjunction analyses identified regions in which the disorders showed common and distinct patterns of volumetric alteration. Both disorders were associated with lower grey-matter volume relative to healthy individuals in a number of areas. Conjunction analysis showed smaller volumes in both disorders in clusters in the dorsomedial and ventromedial prefrontal cortex, including the anterior cingulate cortex and bilateral insula. Group comparisons indicated that findings of smaller grey-matter volumes relative to controls in the right dorsolateral prefrontal cortex and left hippocampus, along with cerebellar, temporal and parietal regions were more substantial in major depression. These results suggest that MDD and BD are characterised by both common and distinct patterns of grey-matter volume changes. This combination of differences and similarities has the potential to inform the development of diagnostic biomarkers for these conditions.

442 citations

References
More filters
Reference EntryDOI
11 Jun 2013

113,134 citations

Journal ArticleDOI
TL;DR: The relative simplicity, reliability, and validity of the GAS suggests that it would be useful in a wide variety of clinical and research settings.
Abstract: † The Global Assessment Scale (GAS) is a rating scale for evaluating the overall functioning of a subject during a specified time period on a continuum from psychological or psychiatric sickness to health. In five studies encompassing the range of populations to which measures of overall severity of illness are likely to be applied, the GAS was found to have good reliability. GAS ratings were found to have greater sensitivity to change over time than did other ratings of overall severity or specific symptom dimensions. Former inpatients in the community with a GAS rating below 40 had a higher probability of readmission to the hospital than did patients with higher GAS scores. The relative simplicity, reliability, and validity of the GAS suggests that it would be useful in a wide variety of clinical and research settings.

4,799 citations


"Prevalence and Characteristics of U..." refers background or methods in this paper

  • ...If patients exhibit bipolar symptoms that impair everyday functioning, treatment with a mood stabilizer or an atypical antipsychotic may be useful.(21) In conclusion, this study shows that more than onethird of patients with MDE also have subthreshold hypomania or mania, which suggests the existence of an unrecognized bipolar subgroup that can be distinguished from pure MDD by several validators....

    [...]

  • ..., unpublished data, April 2008), known risk factors for bipolar disorder, previous response to antidepressants, current treatment, and functional status determined by the physician using the Global Assessment of Functioning.(21) Comorbidity was assessed using the Mini International Neuropsychiatric Interview(22) and diagnosed using symptom checklists by DSM-IV TR criteria for substance abuse and addiction, panic disorders, obsessive-compulsive disorders, social phobias, generalized anxiety disorders, eating disorders, borderline personality disorders, and attention-deficit/hyperactivity disorder (results to be reported elsewhere)....

    [...]

  • ...Exclusion criteria were acute psychiatric or nonpsychiatric emergencies, prominent somatic illness, or inability to complete the 32-item revised Hypomania Checklist.20 DATA COLLECTION Patients were evaluated at a single assessment with the participating psychiatrist, who completed a case report form for each patient, incorporating inclusion criteria, sociodemographic variables (age, sex, and marital status), inpatient or outpatient status, history of psychiatric symptoms (mood symptoms, postpartum depression, and suicide attempts), previous psychiatric hospitalization, features of the current depressive episode, bipolar symptoms listed in the DSM-IV-TR diagnostic criteria for bipolar disorder (J.A., J.-M.A., C.L.B., G.P., E.V., and A.H.Y., unpublished data, April 2008), known risk factors for bipolar disorder, previous response to antidepressants, current treatment, and functional status determined by the physician using the Global Assessment of Functioning.21 Comorbidity was assessed using the Mini International Neuropsychiatric Interview22 and diagnosed using symptom checklists by DSM-IV TR criteria for substance abuse and addiction, panic disorders, obsessive-compulsive disorders, social phobias, generalized anxiety disorders, eating disorders, borderline personality disorders, and attention-deficit/hyperactivity disorder (results to be reported elsewhere)....

    [...]

Journal ArticleDOI
TL;DR: The Mini International Neuropsychiatric Interview (MINI) as mentioned in this paper is a short diagnostic structured interview (DSI) developed in France and the United States to explore 17 disorders according to Diagnostic and Statistical Manual (DSM)-III-R diagnostic criteria.

3,143 citations

Journal ArticleDOI
TL;DR: Depression is the fourth leading cause of disease burden, accounting for 4.4% of total DALYs in the year 2000, and it causes the largest amount of non-fatal burden, covering almost 12% of all total years lived with disability worldwide.
Abstract: Background The initial Global Burden of Disease study found that depression was the fourth leading cause of disease burden, accounting for 3.7% of total disability adjusted life years (DALYs) in the world in 1990. Aims To presentthe new estimates of depression burden for the year 2000. Method DALYs for depressive disorders in each world region were calculated, based on new estimates of mortality, prevalence, incidence, average age at onset, duration and disability severity. Results Depression is the fourth leading cause of disease burden, accounting for 4.4% of total DALYs in the year 2000, and it causes the largest amount of non-fatal burden, accounting for almost 12% of all total years lived with disability worldwide. Conclusions These data on the burden of depression worldwide represent a major public health problem that affects patients and society.

1,698 citations